| Product NDC: | 61953-0001 |
| Proprietary Name: | Human Albumin Grifols |
| Non Proprietary Name: | Albumin (Human) |
| Active Ingredient(s): | 10 g/50mL & nbsp; Albumin (Human) |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 61953-0001 |
| Labeler Name: | Instituto Grifols, S.A. |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA103352 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19950217 |
| Package NDC: | 61953-0001-2 |
| Package Description: | 1 VIAL in 1 CARTON (61953-0001-2) > 100 mL in 1 VIAL (61953-0001-4) |
| NDC Code | 61953-0001-2 |
| Proprietary Name | Human Albumin Grifols |
| Package Description | 1 VIAL in 1 CARTON (61953-0001-2) > 100 mL in 1 VIAL (61953-0001-4) |
| Product NDC | 61953-0001 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | Albumin (Human) |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19950217 |
| Marketing Category Name | BLA |
| Labeler Name | Instituto Grifols, S.A. |
| Substance Name | ALBUMIN (HUMAN) |
| Strength Number | 10 |
| Strength Unit | g/50mL |
| Pharmaceutical Classes | Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] |